The first batch of the Roche antibody cocktail drug arrived in the country on Monday, according to an official announcement by Roche India and Cipla Limited. It is one of the blocking mechanisms that is working against the Covid-19 virus," Doctor Naresh Trehan, Chairman and MD of Medanta hospital told ANI. "We are glad to now have access to Monoclonal Antibody Therapy in India. This fast and effective treatment for COVID -19 will save patients at the highest risk from falling critically ill, getting hospitalized or possibly dying of complications from Covid-19. The doctor, however, said that patients are advised to check with their doctor if monoclonal antibody therapy may be beneficial to them in the treatment of their Covid-19 infection.

Source: Mint May 26, 2021 10:07 UTC